Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
HoUng Kim, Rieke Alten, Fraser Cummings, Silvio Danese, Geert D’Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, JongHyuk Lee, James O. Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven Simoens, Rene Westhovens, Ji Hoon Jeong & Laurent Peyrin-Biroulet. (2021) Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13:1.
Read now
Read now
A. Caban, K. Pisarczyk, K. Kopacz, A. Kapuśniak, M. Toumi, C. Rémuzat & A. Kornfeld. (2017) Filling the gap in CNS drug development: evaluation of the role of drug repurposing. Journal of Market Access & Health Policy 5:1.
Read now
Read now
Articles from other publishers (5)
Jyosna Devi Ravula, Ramakrishna Nirogi & Manthan D. Janodia. (2023) Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations. Journal of Pharmaceutical Sciences 112:8, pages 2146-2175.
Crossref
Crossref
D. J. Hayes & K. J. Escott. 2022. Drug Repurposing. Drug Repurposing
52
73
.
Ciska Verbaanderd, Ilse Rooman, Lydie Meheus & Isabelle Huys. (2020) On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology 10.
Crossref
Crossref
Basant Amarji, Sara Nidal Abed, Ujjawal Bairagi, Pran Kishore Deb, Omar Al-Attraqchi, Anup Avijit Choudhury & Rakesh K. Tekade. 2018. Dosage Form Design Considerations. Dosage Form Design Considerations
637
668
.
Mohamed Elsaed Ebada. (2017) Drug repurposing may generate novel approaches to treating depression. Journal of Pharmacy and Pharmacology 69:11, pages 1428-1436.
Crossref
Crossref